First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
The centre is equipped with the most modern tools and provides an environment soothing for all professionals and patients
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
CMG1A46 is an investigational T cell-engager with potential to deeply deplete uncontrolled B cells present in autoimmune diseases such as lupus
Glenmark Life Sciences has reported total income of Rs. 515.41 crores during the period ended September 30, 2024
Subscribe To Our Newsletter & Stay Updated
